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Abstract 
While the nutrient limited fed-batch technology is the standard of the cultivation of microorganisms and production 
of heterologous proteins in industry, despite its advantages in view of metabolic control and high cell density growth, 
shaken batch cultures are still the standard for protein production and expression screening in molecular biology and 
biochemistry laboratories. This is due to the difficulty and expenses to apply a controlled continuous glucose feed to 
shaken cultures. New ready-made growth media, e.g. by biocatalytic release of glucose from a polymer, offer a simple 
solution for the application of the fed-batch principle in shaken plate and flask cultures. Their wider use has shown 
that the controlled diet not only provides a solution to obtain significantly higher cell yields, but also in many cases 
folding of the target protein is improved by the applied lower growth rates; i.e. final volumetric yields for the active 
protein can be a multiple of what is obtained in complex medium cultures. The combination of the conventional 
optimization approaches with new and easy applicable growth systems has revolutionized recombinant protein 
production in Escherichia coli in view of product yield, culture robustness as well as significantly increased cell densi-
ties. This technical development establishes the basis for successful miniaturization and parallelization which is now 
an important tool for synthetic biology and protein engineering approaches. This review provides an overview of the 
recent developments, results and applications of advanced growth systems which use a controlled glucose release as 
substrate supply.
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Background
For many reasons Escherichia coli is still the preferred 
choice as a host system for protein production. With rela-
tively low costs one can achieve high biomass and high 
protein yield in only short cultivation times. Further-
more, E. coli is extremely well-studied in its biochemical 
and physiological characteristics. With a wealth of tools 
available E. coli also can be easily adapted as needed by 
genetic manipulation. However, even though the general 
procedure for protein production is straightforward, 
protein aggregation during expression is still a major 
obstacle. Different approaches are commonly applied 
to address this problem, and to optimize protein fold-
ing while maximizing protein expression. The currently 
available expression systems with their advantages and 
pitfalls have been regularly reviewed [1–4]. A smart com-
bination of the different parts of the system (e.g. prokar-
yotic or eukaryotic host organism, type of plasmid with 
its specific features) can lead to an improved expression. 
Additional conventional approaches for protein expres-
sion optimization are the coexpression of chaperons, use 
of codon optimized genes, alternate protein tags, change 
of cultivation medium, production process optimization 
[2, 5]. The choice of the system influences the success 
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of proper protein folding and hence the production of 
active, soluble protein. Even more specialized systems 
facing folding problems have been developed. The pre-
expression of Erv1p sulfhydryl oxidase and disulfide bond 
isomerases for example is a robust technique for the pro-
duction of disulfide bonds containing proteins [6, 7].
Since every protein is different, the expression and 
purification strategies must be defined for each single 
case. In their review, Gräslund et al. [2] summarized that 
there are many choices to make when expressing pro-
teins regarding all the parts of the system; e.g. selection 
of E. coli strain, the fusion of the protein with a His-tag 
or another tag, the application of a T7 RNA polymerase 
expression system or another regulated promoter sys-
tem, and finally the choice of the medium and cultivation 
conditions. They published a consensus protocol which 
they agreed to be a good starting-point when aiming to 
produce a recombinant protein. Nevertheless, success is 
protein dependent and a robust and ever-working strat-
egy is still missing. They pointed out that the choice of 
the growth strategy has a significant influence on the suc-
cess of protein expression. A major concern is the direct 
correlation of the degree of aeration and the cultivation 
conditions such as temperature and medium used, with 
the expression level and the solubility of a recombinant 
protein [2]. However, this is rarely considered in molecu-
lar laboratories even though one is clearly aware of this 
fact in the field of biotechnology and bioprocess. Dur-
ing recent years, finally the direction of approach has 
changed. Possible solutions offered, tried to address the 
problem via optimizing the cultivation medium. One of 
these developments for high-level protein production 
is the autoinduction system [8], which works with the 
T7-RNA polymerase based pET plasmids and other iso-
propyl beta-D-thiogalactopyranoside (IPTG)-inducible 
bacterial expression systems under the control of lac 
operon regulatory elements. In the first growth phase 
E. coli consumes the preferred carbon substrate glucose 
until depletion before the diauxic shift to lactose con-
sumption induces the protein expression. Additionally, 
the cells start to use glycerol as a second major carbon 
source which is available in the system.
However, an autoinduction system does not neces-
sarily provide any means of control in terms of cultiva-
tion conditions and hence the metabolic state of the 
production strain. Unlimited availability of nutrients 
and exponential growth in batch type systems lead to 
the production of side-metabolites like acetate and the 
subsequent acidification of the cultures [9]. On the con-
trary, the deamination of amino acid substrates, which 
derive from the utilization of peptones or yeast extract 
as a carbon source, can cause an increase in pH (since 
excess ammonia is secreted into the medium) [10]. Both 
processes are a major reason for flask-to-flask variations 
[11, 12]. The rate of supply of the different nutrients in 
combination with the oxygen availability influence cell 
growth and protein expression substantially. The balance 
of all metabolic rates is a major issue for well controlled 
and robust expression—a challenge due to changing 
specific amino acid composition of the protein, which 
affects directly the cellular pools of all distinct amino 
acids and due to the sensitive regulation of the pathways 
of synthesis and transport of the amino acids also global 
responses. The issue of controlled cell physiology and 
process robustness, i.e. limitation of batch-to-batch vari-
ation, is well considered in industrial bioprocesses where 
glucose based mineral salt media are normally used and 
complex additives are avoided [13, 14]. Control of the 
cell metabolism is obtained by continuous feed of the 
only carbon source in a way that the feeding rate limits 
the uptake rate. This nutrient limited fed-batch technol-
ogy is the dominating technology in the bioindustry to 
reach high cell density fermentations. The feed rate of a 
highly concentrated nutrient solution, which is glucose in 
most cases, directly affects the growth rate and the rate of 
respiration. As the metabolic flux through the glycolysis 
is closely related to the respiratory activity by the reduc-
tion of NAD+ to NADH +  H+, the glucose feed rate is 
directly linked to the consumption of oxygen. Oxygen 
supply is always a limitation in aerobic processes due to 
the limited solubility of oxygen in aqueous media. Dur-
ing batch cultivations in shaken cultures where all avail-
able substrate is added from the start of the cultivation, 
optimal oxygen levels require 10–20  % culture volume 
in relation to the flask volume [15]. A controlled carbon 
source (usually glucose) supply is a key way to control 
the volumetric oxygen consumption rate. Therefore, the 
fed-batch cultivation where the carbon source is added 
continuously is the preferred alternative to a batch cul-
tivation, as metabolic rates can be controlled [16]. If the 
volumetric oxygen consumption rate is smaller than the 
volumetric oxygen transfer rate, the culture experiences 
aerobic conditions independent on cell density, although 
the specific growth rate (i.e. the growth rate of a single 
cell) is lower the higher the cell density is (cf. Fig. 1a). It is 
however clear that at a higher volumetric oxygen transfer 
rate, the glucose consumption rate and thus the final cell 
density is higher compared to cultures with a low volu-
metric oxygen transfer rate. High cell densities can there-
fore be reached if a high oxygen transfer rate is enabled 
and a proper control of the glucose flux is guaranteed 
[16].
While in industry mechanical pumps regulate the sub-
strate feed rate to maintain a certain limitation of the 
carbon source (see Fig.  1b, c), it remained a challenge 
to apply the fed-batch technology in smaller laboratory 
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cultivation systems, such as shake flasks and microw-
ell plates. Since a few years pump-independent intelli-
gent growth systems with internally controlled substrate 
release are available and make the fed-batch technology 
attainable for small scale cultivation. The idea of an inte-
grated nutrient supply system is not new and has been 
first published as early as 1958. An overview of integrated 
feed systems can be found in Fig. 2. In 1958 Tyrell et al. 
[17] used a two phase system composed of a nutrient 
agar covered by liquid growth medium (Fig.  2a). Later 
this system was adapted to Streptomyces cultures provid-
ing controlled ammonia feed [18]. Recently, the described 
principles were transferred to intelligent growth systems 
available for small scale cultivation in different formats. 
One example is the Feed Bead® technology [19] where 
silicone elastomer discs containing glucose crystals are 
added to the cultivation and release the substrate by dif-
fusion (Fig. 2b). The only way to control substrate release 
is implemented by the amount of beads added to the cul-
ture. Based on the same principle of diffusion, Wilming 
and colleagues [20] developed a special microwell plate. 
Here the feeding solution reaches the wells with cultiva-
tions through a capillary system filled with a hydrogel. 
The substrate diffuses through the hydrogel into the cul-
ture well, and the feed rate can be adjusted by changes 
in the geometry of the channel and the substrate concen-
tration gradient. In contrast to this, the EnBase® cultiva-
tion technology does not rely on substrate diffusion, but 
involves a possibility to control the feed rate without the 
need for an external pumping system [11, 21]. Instead, a 
soluble polysaccharide is degraded by a biocatalyst, and 
thus glucose is gradually released into the culture as the 
primary carbon source (Fig. 2c). The amount and activity 
of the biocatalyst directly controls the release rate of 
glucose over the time. This technology was specifically 
optimized for recombinant protein production by con-
sidering the following points: firstly, a constant delivery 
of glucose until the end of the protein production phase. 
Secondly, a self-sustainable pH by the addition of a bal-
anced mixture of inorganic and organic ammonia com-
pounds during glucose limitation. Thirdly, a possibility 
to adapt the system to different aeration conditions by 
adjustment of the amount of enzyme added [11, 21]. Dif-
ferent studies convincingly show that growth and pro-
tein production are not necessarily connected, but that a 
limitation of the dissolved oxygen during the production 
phase even may be advantageous [22–24].
Furthermore, the system has been optimized for ease 
of applicability and is available as pre-sterilized tablets 
which contain the full medium. These tablets are simply 
added to sterile water and dissolve in the first minutes of 
cultivation. Studies have shown that the technology can 
be easily combined with conventional approaches to yield 
not only higher amount of a target protein through the 
higher cell density [21, 25, 26], but also in many cases a 
higher amount of correctly folded protein per cell [26, 
27]. Modern screening systems, such as RAMOS, Bio-
lector and PreSens’ SensorDish with an ability for on-
line monitoring of growth data provide excellent tools to 
optimize the growth and expression conditions [28–32].
This positive effect is obtained due to lowered growth 
rate, which in turn is related to a lowered rate of protein 
synthesis and an improved balance between the synthe-
sis and the folding rates. The current list of successful 
expression examples with EnBase and similar continuous 
release techniques (see Table 1) indicate, that controlled 
Fig. 1 Overview of the fed-batch principle. a The oxygen transfer capacity kLaC in a bioreactor limits the volumetric oxygen consumption rate rO 
if aerobic conditions need to be maintained. Due to the relationship between the volumetric rates for growth (rX), substrate consumption (rS) and 
oxygen (rO), rO can be controlled by a control of the volumetric substrate uptake by a controlled substrate feed (F Feed rate, V reactor volume, Si 
substrate concentration in the feed solution). As the volumetric rates are the product of the specific rates (qO, μ, qS) with the actual biomass X, at 
a constant feed rate the specific rates decrease at increasing biomass and thus the level of dissolved oxygen is dependent on the feed rate, but 
largely independent on the cell density. b Principle view of a fed-batch bioreactor with a feed reservoir and the fee pump which controls the fee 
rate. c A typical simulation plot for a fed-batch cultivation on mineral salt medium with glucose as the only carbon source and a constant feed rate. 
The graph shows the Feed rate (F), dissolved oxygen tension (DOT), biomass (X), Substrate (S, often glucose) and the specific growth rate (my)
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growth systems are not only the solution if current stand-
ard cultivation methods do not succeed but become 
a standard approach. This review aims to expand the 
researchers’ current view on recombinant protein pro-
duction towards technologies which became recently 
available (see Table  2). These technologies promise to 
further advance protein production strategies improving 
protein quality and yield alike.
Application of advanced growth systems in E. coli 
cultivations
Controlled metabolism by a fed-batch type of opera-
tion incorporated into microbial growth systems like 
the EnBase technology comprise several benefits such 
as aerobic metabolism to high cell densities and lower 
production of acidifying side products and thus a sta-
ble pH over long cultivation times. Also the growth at a 
constant volumetric growth rate, i.e. approximately lin-
ear increase of OD, is an advantage compared to expo-
nentially growing cultures in view of robustness and 
reproducibility. As a result, the final product yield is less 
independent on the time or cell density of induction [11, 
21]. For example, Peck et  al. [25] observed eight times 
higher cell densities and an increased protein yield per 
cell producing capripoxyvirus proteins which causes 
severe diseases in sheep and cattle. The production 
of Tissue-type plasminogen activators (t-PA) is com-
monly done in mammalian cell cultures. However, one 
faces problems like low yields, long cultivation times 
and high costs. Mahboudi et  al. [33] has successfully 
overcome these problems by producing a biologically 
active truncated form of the tissue plasminogen activa-
tor in E. coli BL21 (DE3) using the EnBase technology. 
They obtained an 8 to 20-fold increase in cell density and 
Fig. 2 Overview of cultivation systems with integrated substrate supply. a Multilayer system by [17, 21]. A medium-agar was covered by a broth 
in which the bacteria were cultivated. b Feed Bead® System by Jeude et al. [19]. Silicone elastomer discs (feed beads) releasing substrate to the 
medium. c Principle of the integrated substrate delivery system with the EnBase technology [11]. Dissolved polysaccharides being part of the culti-
vation medium are degraded to glucose molecules by the addition of defined enzyme concentration
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Table 1 Overview of produced target molecules with advanced growth system
Target group Specific target References
Enzymes Monomeric variants of Trypanosoma brucei triosephosphate isomerase(TIM) [21]
Drosophila melanogaster multifunctional enzyme type 2 (MFE2) [11]
A-domain of human protein disulphide isomerase (PDI) [11]
Lactobacillus alcohol dehydrogenase (ADH) [11]
Tryptophan synthase complex [52]
Formate dehydrogenase (FDH) from Candida boidinii [93]
Human NSUN4, 5-methylcytosine RNA methyltransferase [34]
SdrE protein—surface adhesin of Staphylococcus aureus [35]
Zmp1—zinc-dependent metalloprotease [36]
Human lipoxygenases hALOX15 [38]
Esterase, Est 22; Axe A and Axe B [44, 54]
Rhizopus oryzae lipase (ROL) [84]
Purine nucleoside phosphorylases (PNPs) [26, 103–105]
Alkaline phosphatase (PhoA) and a phytase, AppA [58]
Surface lipoprotein SitA from Staphylococcus pseudointermedius [42]
Endopolygalacturonase from Aspergillus niger [32]
Chloramphenicol acetyltransferase I (CATI) [45]
Alkane monooxygenase (AlkB) [43]
Pseudomonas aeruginosa lipoxygenase (PA-LOX) [39]
Sortases: SrtC1-2b, Srt2-2b, SrtA [46]
Nitrilases [51]
Rat lactate dehydrogenase [53]
Zebrafish ALOX2 (lipoxygenase) [40]
Zinc-dependent metalloprotease Zmp1 [101]
α-amylase AmyM from Geobacillus stearothermophilus [88]
Rhizopus oryzae lipase (ROL) in P. pastoris [84]
Antibodies, antibody fragments, other binding 
proteins
Two single-domain antibodies (sdAbs) [68]
Four Fab fragments [24]
Anti-interleukin 1ß scFv [58]
Zinc transporter 8 autoantibodies (ZnT8A) [49]
Different nanobody variants [60]
10 scFv and 10 Fab fragments [70]
DNA binding protein LiaR [41]
DNA binding transcriptional regulator NadR (Neisseria adhesin A regulator) [100]
RNA-binding proteins: nucleolin EF-hand domain-containing protein D2 (EFHD2), 
splicing factor U2AF (U2AF653) serine/arginine-rich splicing factor 1 (SRSF1)
[47]
Fully reduced active RNase inhibitor: contains leucine-rich repeat motifs (LRR) [22, 48, 98]
Disulfide bonded proteinsa Reteplase, a fragment of tissue plasminogen activator which contains only the kringle 
2 and protease domains (nine disulfide bonds)
[7]
Chimeric-truncated form of tissue-type plasminogen activator (t-PA) [33]
Human leukemia inhibitory factor (hLIF)—a cytokine (three intramolecular disulfide 
bonds)
[50]
AppA, a phytase (four disulfide bonds) [58]
Human growth hormone hGH [58]
Human-derived glycosyltransferase GalNAcT2 (five disulfide bonds) [59]
Bioactive peptides Super-large non-ribosomal peptide synthetase valinomycin synthetase subunits Vlm1 
(370 kDa) and Vlm2 (284 kDa)
[72]
Nonribosomal peptide valinomycin [73, 75, 106]
Polyketide macrolide 6-deoxyerythronolide B (6dEB) in Bacillus subtilis [76]
Ribosomal peptide microviridin [71]
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an improved specific activity. Growth systems that can 
offer controlled cultivation conditions can be used as 
an easy tool for the production of a variety of proteins 
in E. coli—usually E. coli BL21 (DE3). For example, the 
multifunctional enzyme 2 from Drosophila [27] and the 
human MTERF4-NSUN4 protein complex that regulates 
mitochondrial ribosome biogenesis [34] enabling crys-
tallization of both proteins, Sdr proteins from Staph-
olococcus areus [35], a zinc-dependent metalloprotease 
Zmp1 from Clostridium difficile [36], human proteins 
such as different arachidonate lipoxygenase enzymes 
[37, 38], lipoxygenase from Pseudomonas aeruginosa 
[39] and zebrafish [40], the cytosolic response regulator 
LiaR from Enterococcus faecalis expressed in the pET-
Duet vector [41], the metal-dependent surface lipopro-
tein SitA from Staphylococcus pseudointermedius [42] or 
another metalloenzyme like the alkane monooxygenase 
AlkB [43] were successfully produced employing the 
EnBase technology. Furthermore, a family VIII esterase 
Est22 [44], the E. coli chloramphenicol acetyltransferase 
I (CATI) [45], different sortase enzymes from Strepto-
coccus [46], and proteins which do not express in com-
monly applied media like the phosphoprotein nucleolin 
[47] and eukaryotic ribonuclease inhibitor [22, 48] could 
be successfully expressed in E. coli by the application of 
an advanced growth system. To allow a tunable expres-
sion by variation of the activity of the T7 RNA poly-
merase, enzyme based substrate supply media can be 
combined with Lemo21 E. coli (DE3). In the Lemo Sys-
tem the expression of the natural inhibitor of T7 RNA 
polymerase, the T7 lysozyme (lysY), is controlled by the 
rhamnose promoter. The amount of rhamnose controls 
the activity of the T7 RNA polymerase and is chosen at 
a concentration to minimize the cellular stress, which 
has been useful  for the functional expression of mem-
brane proteins and other difficult to express targets. One 
example is the expression of specific zinc transporter 8 
autoantibodies (ZnT8A) important in diabetes [49].
Another example for successful combination of dif-
ferent optimization strategies was the functional pro-
duction of the human leukemia inhibitory factor (LIF): 
codon-optimization for high expression, application of 
Origami B (DE3) with thioredoxin coexpression for cor-
rect disulfide bond formation and Profinity eXact™ for 
simpler purification was combined with the EnBase tech-
nology for high cell density cultivation [50]. The soluble 
rhLIF yield was estimated to be about 1  mg  g−1 of wet 
weight cells, with a purity of >98 %. In addition, a study 
reporting the discovery of new nitrilases for dinitriles 
describes the combination of E. coli Origami B (DE3), 
Table 1 continued
Target group Specific target References
Others Plasmid DNA [77–79]
Capripoxvirus proteins 64 and 95 [25]
Fusion protein: multiple-epitope antigen CTB-UE [69]
Saporin L3 from Saponaria officinalis in Pichia pastoris [81]
Human immunoglobulin receptors in P. pastoris (extracellularly) [83]
a Antibodies and antibody fragments are mentioned in a separate section
Table 2 Commercially available intelligent growth media for the production of recombinant proteins
Working principle Product name Company Application
EnBase® technology: controlled release 
through enzymatic degradation of polymers
EnPresso® B BioSilta Ltd Protein production with E. coli
EnPresso® Y Defined BioSilta Ltd Protein production with yeasts
EnPresso® B Defined Nitrogen-free BioSilta Ltd Production of 15N-labelled proteins 
in E. coli
Autoinduction technology Overnight Express™ Autoinduction 
System 1
Merck-Millipore Novagen Lac-promoter based protein pro-
duction with E. coli
MagicMedia™ Thermo Fisher Scientific Production of recombinant proteins 
in E. coli with T7 RNA polymerase 
system
Slow-release polymer systems for substrates, 
including glucose
FeedBeads® Kuhner Shaker Microbial growth under substrate 
controlled (limited) conditions
FeedPlate® PS—Biotech Microbial growth under substrate 
controlled (limited) conditions
Unknown principle FIFTYOD Prozomix Production of recombinant proteins 
in E. coli  BL21
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arabinose induced co-expression of GroEL/ES chaper-
ones, low IPTG concentration, expression temperature 
of 25 °C and the EnBase technology as the most efficient 
method after optimization of several cultivation param-
eters [51]. Another study [52] combined a pET vector 
system and the commercial E. coli strain BL21-Codon-
Plus (DE3)-RIPL which expresses additional copies of 
certain t-RNA genes (argU, ileY, leuW) with EnBase. For 
this protein the final yield was increased by a factor of 16 
compared to LB (Luria Bertani) medium. A further study 
applied E. coli OverExpress C41 BL21(DE3) cells with a 
reduced activity of the T7 RNA polymerase and a higher 
tolerance membrane and other toxic proteins. These cells 
were used to produce tetrameric rat lactate dehydroge-
nase in 50 ml EnPresso growth system at the same level 
as obtained with 1  L traditional LB medium [53]. The 
authors succeeded with  the purified protein to obtain 
the crystal structure. Also Mokoena et al. [54] were able 
to express two carboxyl ester hydrolases identified in a 
metagenomic study in EnPresso medium. These enzymes 
can de-acetylate cephalosporins which are valuable build-
ing blocks in the production of semi-synthetic β-lactam 
antibiotics. The production was possible, because an 
intelligent growth system was employed. In a bigger 
study Achenbach et  al. expressed a large set of proteins 
for in vitro protein synthesis with EnPresso medium [55].
Disulfide bond containing proteins
The correct formation of disulfide bonds, a major post-
translational modification, is important for the produc-
tion of many proteins, in particular secreted mammalian 
proteins like hormones, growth factors and immuno-
globulins [56, 57]. One common approach is the secre-
tion of such proteins to the periplasm in E. coli to ensure 
a favorable folding environment [1]. This approach can be 
combined with a growth system providing the controlled 
cultivation conditions as was successfully demonstrated 
by Matos et al. [58] for a four disulfide bond containing 
protein and by Nguyen et al. [7] for a nine disulfide bond 
containing protein (vtPA). In the latter case significant 
improvements in active protein yield (800 times), with a 
100-fold increase in activity and in cell density (10 times) 
could be achieved. A very recent example is the expres-
sion in E. coli of functional recombinant human glyco-
syltransferase GalNAcT2 with five disulfide bonds [59]. 
The protein sequence was optimized towards expres-
sion in E. coli and a plasmid was co-expressed which 
encodes the sulfhydryl oxidase Erv1p and the protein 
disulfide isomerase PDI facilitating improved forma-
tion of disulfide bonds. This set-up was combined with 
the application of E. coli SHuffle® strain and EnPresso B 
cultivation medium. Due to the reproducible conditions 
provided by the medium, it was possible to scale-up the 
whole expression system to the 1.5 L fermentation scale. 
Furthermore, the protocol to produce nanobodies in E. 
coli SHuffle® showed an enhancement from 22 to 45 mg 
L−1 when cells were cultured with the advanced growth 
system instead of LB [60].
Autoinduction
It is well known that lactose can replace IPTG as potent 
and cheap inducer for recombinant protein production 
[8, 61]. This has been realized in autoinduction media 
(e.g. ZYM autoinduction medium from Novagen) which 
provide the benefit that culture does not need to be inter-
rupted for induction, which is a big advantage in large 
screening campaigns but also in view of the time sched-
uling of shake flask experiments. By autoinduction the 
protein is expressed automatically by derepression of 
the Plac-derived promoter variant when glucose becomes 
exhausted, due to the well-known diauxic behavior 
which has been originally described in the PhD thesis by 
Jacques Monod [62]. This diauxic regulation is a result 
of two concurrent events, glucose catabolite repression 
and inducer exclusion. Studier [8] describes that by using 
autoinduction media, the induction is smooth and typical 
drawbacks like strong formation of inclusion bodies are 
a lower problem, possibly due to slower growth rate and 
lower expression of the effective T7 RNA polymerase. 
From understanding of the diauxic adaptation [63] one 
might even assume that induction of the stress responses 
during the transient from glucose to lactose consumption 
lead to this improved robustness. While it is known that 
lactose can be also applied in combination with glucose 
limited fed-batch cultivations [64], recently Ukkonen 
et  al. [23] have shown that glucose limitation is impor-
tant rather than glucose starvation. Protein expression 
after the diauxic switch is working well with a continuous 
background feeding of glucose. If this background feed-
ing of glucose is adjusted properly, lactose only serves as 
an inducer, but is not catabolized. In a paper by Mayer 
et  al. [65] the concentration of lactose stayed approxi-
mately constant during a 24  h cultivation with a back-
ground enzymatic supply of glucose while the product 
was smoothly produced in a correctly folded form at rea-
sonable high cell densities (OD600 of >20).
Oxygen
In common shake-flask cultivations the availability of 
oxygen is usually problematic. And even if the oxygen 
availability and subsequently the oxygen transfer rates 
can be improved, the commonly applied media cannot 
facilitate the growth to very high cell densities. However, 
feed-controlled systems can balance this through con-
stant substrate limitation and hence provide robust cul-
tivation conditions even at higher oxygen transfer rates. 
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This was shown by Ukkonen et al. [66] and also by Pilarek 
et al. [67] in two different approaches. Ukkonen et al. [66] 
combined the enzyme based substrate delivery technique 
with Ultra Yield Flasks (Thomson Instruments) char-
acterized by four-fold increased oxygen transfer. While 
standard media like LB or TB (Terrific Broth) lead to a 
high amount of insoluble protein, the application of the 
feed-based system enables higher biomass production 
(up to 20  g L−1) and higher enzyme activity (>100-fold 
improvement). Pilarek et  al. [67] provided additional 
oxygen to their miniaturized cultures by the addition of 
perfluorodecalin (PFD) which can be charged with oxy-
gen and will release the oxygen during cultivations while 
taking up CO2. In combination with advanced growth 
systems this lead to a 40 % increase in the OD600 of E. coli 
cultures. Usually perfluorocarbons are applied in mam-
malian cell cultivations, but as demonstrated can also be 
used in bacterial cultivations.
Peptides, antibodies and antibody fragments
Immunoglobulins are applied widely in therapeutic and 
diagnostic applications. The yield of correctly folded, 
functional antibody fragments, such as Fab-fragments, 
is usually rather low. The addition of a signal sequence 
to the Fab-fragment sequence directs the Fab-frag-
ments to the periplasm when expressed in E. coli. Leak-
age of folded fragments into the medium can occur and 
facilitates easy purification. Studies showed that the 
application of an optimized expression system with an 
intelligent growth technology such as EnBase increases 
the amount of total and also extracellular yields [24]. 
Zarschler et  al. [68] were able to increase the yield of 
functional and soluble signal domain antibodies of up to 
200  mg L−1. In another study, the expression level of a 
vaccine epitope (CTB-UE) which can induce cellular and 
humoral immune responses and attenuate Heliobacter 
pylori infections could be increased by almost 15 % with 
a solubility rate of about 90 % [69]. Recently, the CyDisCo 
system was introduced which enables production of 
disulfide bonded proteins in the cytoplasm with reducing 
pathways by coexpression of a catalyst of disulfide bond 
formation and a catalyst of disulfide bond isomerization 
[6, 7]. Gaciarz et al. [70] show the efficient formation of 
ten natively folded and active scFvs with a yield of up to 
240 mg L−1 and 10 Fab antibody fragments up to 42 mg 
L−1 by using jointly the CyDisCo and EnBase technolo-
gies. The use of intelligent growth medium clearly out-
performed standard media like TB or LB.
Also the production of translationally modified bioac-
tive ribsosomal peptides seems to benefit from a growth 
control. The yield of novel microviridin variants in E. coli 
was improved by using EnPresso B medium directly from 
fosmids with the modifications and proof of their biologi-
cal activity [71].
Non‑ribosomal peptides
Also the production of non-ribosomal peptides is chal-
lenging due to the need to functionally express the super-
large multidomain nonribosomal peptide synthetase 
which often consist of more subunits, the need to express 
the phosphopantetheinyltransferase for the activation of 
the thiolation domains and eventually additional factors, 
and finally to keep the cell alive to drive the synthesis 
of the wanted peptide. As an example we have recently 
expressed successfully the nonribosomal peptide and 
macrolactone antibiotic valinomycin. Its production was 
heavily increased by switching from TB to the EnBase 
cultivation system [72–74]. The fed-batch process is 
advantageous for the production of such complicated 
systems as a stable metabolic state can be maintained 
over a longer period of time [73, 74]. Large proteins are 
very often prone to misfolding and aggregation, but the 
selection of a fine-tuned cultivation system comprising 
of a weak promoter, low induction conditions and con-
trolled growth conditions made the production of the 
peptide with two separate domains, encoded as separate 
genes (domain 1 is 370 kDa, domain 2 is 284 kDa) pos-
sible, and the final yield of valinomycin was even compa-
rable to the productivity of several native Streptomyces 
strains [72, 75]. A 33-fold increase, leading to 10 mg L−1 
of product was obtained. Additionally, the NRPS was 
used to produce the final product, the antibiotic valino-
mycin. Such processes usually require a quite long cul-
tivation time (>50 h), and hence cannot work in a batch 
cultivation environment. It is interesting to remark, that 
the EnBase technology also was the solution for the pro-
duction of the polyketide 6-deoxyerythronolide with B. 
subtilis. This PKS multienzyme complex was expressed 
under control of the acetoin induced acoA promoter [76].
Other applications of advanced growth systems
Furthermore, studies and the development of new pro-
tocols show that intelligent growth systems are not only 
beneficial when applied for the production of proteins or 
peptides, but can also increase the yield of isolated plas-
mid [77]. The production of gene-libraries is often limited 
to the amount of plasmid produced. Additionally, a large 
number of samples needs to be handled in parallel and 
requires a robotic set-up to enable automated handling. 
This on the other hand demands downscaling of the 
culture volume. It would be of great benefit to achieve a 
high optical density in a small cultivation volume. Pilarek 
et al. [78] and Grunzel et al. [77] showed that it is possi-
ble to miniaturize E. coli cultures while obtaining a high 
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final yield in plasmid when advanced growth systems are 
applied controlling the cultivation conditions. Ramirez 
et al. [79] concluded in a study that the use of their engi-
neered strain together with the enhanced growth system 
is a promising method for plasmid DNA production in 
shake flasks. This demonstrates once more that when 
exploiting bacteria as production factories in general, the 
cultivation conditions are [5] of great importance, and 
should be considered as an essential part during any opti-
mization studies.
For protein production in yeasts the same challenges as 
in E. coli cultures apply. The application of an advanced 
growth systems in yeast cultivations has been success-
fully tested by Grimm et al. [5]. The growth and the abil-
ity to convert a certain substrate of twenty different yeast 
strains was compared in the study. In almost all cases the 
cell mass (measured as wet cell weight) and the substrate 
conversion (in  %) was significantly improved compared 
to cultivations done in standard YEP medium. Potvin 
et al. [80] proposed the application of intelligent growth 
systems in Pichia pastoris cultivations. Recently, studies 
have demonstrated the feasibility of this approach. Yuan 
et al. [81] produced the type 1 ribosome inactivating pro-
tein Saporin L3 from Saponaria officinalis (soapwort) 
leaves which is toxic for E. coli successfully in P. pastoris 
using the EnBase technology. Ruth et al. [82] successfully 
applied the Feed Bead® Technology to study transcrip-
tion factor of P. pastoris and Ashoor et al. [83] to produce 
human immunoglobulin receptors with EnPresso in P. 
pastoris. In the approach by Panula-Perälä et al. [84] the 
slow glucose release of the EnBase technology was used 
as a continuous background energy and carbon supply 
bridging the gaps between methanol pulses needed for 
protein expression under the AOX1 promotor. Such a 
background feeding provided a significant increase in cell 
densities and product activities.
Recently, Grimm and Neubauer [85] published that the 
combination of such growth systems can be easily com-
bined with on-line sensor plates, e.g. for oxygen or pH. 
This enables a controlled cultivation where not only pH, 
OD and temperature can be followed and controlled, but 
also the substrate availability. Therefore, the cultivation 
runs under optimized, robust and reproducible condi-
tions reaching higher cell densities. All these examples 
show that application of advanced growth systems is not 
limited to E. coli. Such systems even have been used with 
Bacilli [86] which is interesting, since Bacilli have native 
amylases which can interfere with the growth system. 
However as amylases are expressed only under nutrient 
limitation, even with Bacilli an initial growth control is 
possible (own non-published experiments). A better con-
trol is obtained if amyE knockouts are used [87]. Ploss 
et  al. [88] used the slow glucose release of the growth 
system to mimic industrial carbon-limited growth condi-
tions of B. subtilis to investigate the expression heteroge-
neity of secretory proteins with α-amylase AmyM from 
Geobacillus stearothermophilus as case example. Other 
applications of EnBase media even included the growth 
of lactobacilli [89, 90] and salmonella [91].
Furthermore, the newly developed growth systems, 
such as EnPresso, are widely compatible with a number 
of cultivation vessels from high-throughput small scale, 
over shake-flasks to larger reactors [48, 92–95], even in 
robotic automated set-ups [32, 96]. The scalability of such 
a system has been demonstrated for the production of 
different proteins by Glazyrina et al. [97], Li et al. [75] and 
Šiurkus et al. [22, 48, 98]. The latter is a great example for 
the successful implementation throughout different cul-
tivation scales. The heterologous expression of RNase 
inhibitors is problematic because of product aggregation 
followed by low product yield. This was due to the unu-
sual structure of this type of proteins characterized by a 
core of leucine-rich repeats in addition to 32 cysteins. To 
screen for the optimal expression system yielding solu-
ble protein, the RNase inhibitor gene was cloned into a 
cytoplasmic expression vector library which contains 45 
vectors differing in promoter strength, ribosomal binding 
sites and fusion tags. A luciferase based protein folding 
reporter system was used to monitor protein aggregation. 
The best conditions (maltose binding protein tag regard-
less promoter strength and ribosome binding sequence) 
were transferred to shake flask scale to establish the opti-
mal substrate feeding rate. Since throughout the screen-
ing process EnBase provided fed-batch conditions the 
cultivations could be easily transferred to the bioreactor 
scale (fed-batch with glucose feed, using MSM medium). 
Cultivations in complex medium (LB medium) were 
done only for comparison. An important conclusion that 
we can draw from this study is that the amount of solu-
ble and active product was instead of being influenced 
by promoter strength (i.e. induction strength) or cultiva-
tion temperature influenced by the specific growth rate 
prior to induction and also the medium composition. 
Differences between the scales did not appear because 
of the cultivation conditions, but rather because of lower 
oxygen transfer rates in small scale shaken cultures 
compared to the rates larger in bioreactors. The study 
Glazyrina et al. [97] comes to a very similar conclusion. 
Here the production of an alcohol dehydrogenase (ADH) 
could be run under comparable conditions from mL- to 
60 L-scale due to the use of a smart cultivation system. 
Their results showed that either fed-batch conditions 
or the conditions provided by the EnBase Technology® 
could be used to achieve much higher cell densities (up 
to 22 g L−1 for the fed-batch and up to 13 g L−1 for the 
EnBase cultivations).
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In general one can summarize that advanced growth 
systems lead to higher protein yield; on average the 
EnBase technology enables at least fivefold higher protein 
yield than the traditional LB.
Finally, in the area of pharmaceutical protein produc-
tion not only the host system plays a role, but also the 
media composition. Mainly mineral media are used. 
Especially when producing proteins in minimal medium 
for subsequent structural characterization by NMR, poor 
growth, low levels of expression, and insufficient labeled 
protein are very often problematic [99]. The application 
of an intelligent growth system can solve this problem 
by addition of a 15N labelled ammonium salt [100, 101]. 
Another example comes from scientists from Vernalis plc 
(UK), who were able to achieve an increase in productiv-
ity from 2.5 to 160 mg L−1 of a 15N-labeled protein [102].
Outlook
During the last decade there have been significant 
advances in the heterologous expression of target pro-
teins in bacterial (in particular E. coli), insect and mam-
malian cell cultures. These developments lead to a steady 
increase in the yield of recombinantly expressed proteins 
of high quality, in shorter time periods, and an overall 
higher success rate for expression of functional, active 
proteins used in downstream applications. Nevertheless, 
the constantly rising need for the production in thera-
peutics and large amounts of protein for biophysical and 
structural analysis does still require the development of 
novel expression technologies in the future, especially, to 
avoid/reduce the eminent problem of protein aggrega-
tion. Recently, this problem has been addressed from a 
different angle, including also the cell physiology and cul-
tivation conditions as part of the solution.
It can be concluded that the application of smart media 
to obtain a controlled and balanced process is important 
to improve protein production. Summarizing, all the bene-
fits of combining smart growth systems with conventional 
approaches and the wide applicability in terms of vessel-
type, strains and production target should be universally 
adapted as a routine growth system in the everyday lab.
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